COVID-19 exposes India’s dependence on China for active pharma ingredients -Kundan Pandey

Share this article Share this article
published Published on Jun 7, 2020   modified Modified on Jun 19, 2020

-Down to Earth

India imports around 90 per cent of APIs used to make antibiotics, says an expert

The novel coronavirus disease (COVID-19) pandemic has revealed India’s overdependence on China for active pharmaceutical ingredients (APIs) — also known as bulk drugs — defined by the World Health Organization as any substances used in finished pharmaceutical products.

India’s pharmaceutical industry is the third-largest in the world in terms of volume.

Two-thirds of the total imports of bulk drugs or drug intermediaries, however, come from China, DV Sadananda Gowda, the Union minister for Chemicals and Fertilizers, told the Lok Sabha on February 2020.

India imports around 90 per cent of APIs used to make antibiotics, according to Ashok Madan, the executive director of the Indian Drug Manufacturer Association.

Please click here to read more.


Down to Earth, 7 April, 2020, https://www.downtoearth.org.in/news/economy/covid-19-exposes-india-s-dependence-on-china-for-active-pharma-ingredients-70272


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close